These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


328 related items for PubMed ID: 18676439

  • 1. Perivascular spaces--MRI marker of inflammatory activity in the brain?
    Wuerfel J, Haertle M, Waiczies H, Tysiak E, Bechmann I, Wernecke KD, Zipp F, Paul F.
    Brain; 2008 Sep; 131(Pt 9):2332-40. PubMed ID: 18676439
    [Abstract] [Full Text] [Related]

  • 2. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M.
    J Neurol Sci; 2004 Aug 30; 223(2):185-93. PubMed ID: 15337621
    [Abstract] [Full Text] [Related]

  • 3. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
    Masek M, Vaneckova M, Krasensky J, Danes J, Havrdova E, Hrebikova T, Seidl Z.
    Neuro Endocrinol Lett; 2008 Aug 30; 29(4):461-6. PubMed ID: 18766142
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.
    Patankar TF, Baldwin R, Mitra D, Jeffries S, Sutcliffe C, Burns A, Jackson A.
    J Affect Disord; 2007 Jan 30; 97(1-3):265-70. PubMed ID: 16919335
    [Abstract] [Full Text] [Related]

  • 7. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 30; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 8. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
    Zhao Y, Traboulsee A, Petkau AJ, Li D.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1092-7. PubMed ID: 18003938
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration?
    Kilsdonk ID, Steenwijk MD, Pouwels PJ, Zwanenburg JJ, Visser F, Luijten PR, Geurts J, Barkhof F, Wattjes MP.
    Mult Scler; 2015 Feb 25; 21(2):155-62. PubMed ID: 25013150
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb 25; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

  • 13. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
    Martin Mdel P, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-Demasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O.
    Arch Neurol; 2009 Aug 25; 66(8):1016-20. PubMed ID: 19667224
    [Abstract] [Full Text] [Related]

  • 14. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):47-54. PubMed ID: 19201003
    [Abstract] [Full Text] [Related]

  • 15. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, Zipp F, Paul F.
    Neurology; 2009 Nov 17; 73(20):1624-7. PubMed ID: 19917984
    [Abstract] [Full Text] [Related]

  • 16. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
    Fox RJ, Kivisakk P, Fisher E, Tucky B, Lee JC, Rudick RA, Ransohoff RM.
    Mult Scler; 2008 Sep 17; 14(8):1036-43. PubMed ID: 18701575
    [Abstract] [Full Text] [Related]

  • 17. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
    Laplaud DA, Berthelot L, Miqueu P, Bourcier K, Moynard J, Oudinet Y, Guillet M, Ruiz C, Oden N, Brouard S, Guttmann CR, Weiner HL, Khoury SJ, Soulillou JP.
    J Neuroimmunol; 2006 Aug 17; 177(1-2):151-60. PubMed ID: 16806500
    [Abstract] [Full Text] [Related]

  • 18. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.
    Vaneckova M, Seidl Z, Krasensky J, Havrdova E, Horakova D, Dolezal O, Burgetova A, Masek M.
    Eur Neurol; 2009 Aug 17; 61(5):278-84. PubMed ID: 19295214
    [Abstract] [Full Text] [Related]

  • 19. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
    Vos CM, Geurts JJ, Montagne L, van Haastert ES, Bö L, van der Valk P, Barkhof F, de Vries HE.
    Neurobiol Dis; 2005 Dec 17; 20(3):953-60. PubMed ID: 16039866
    [Abstract] [Full Text] [Related]

  • 20. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
    Tortorella C, Bellacosa A, Paolicelli D, Fuiani A, Di Monte E, Simone IL, Giaquinto P, Livrea P, Trojano M.
    J Neurol Sci; 2005 Dec 15; 239(1):95-9. PubMed ID: 16209877
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.